Journal of labelled compounds and radiopharmaceuticals p. 425 - 433 (1996)
Update date:2022-08-02
Topics:
Gong, Leyi
Pames, Howard
The preparation of the title compound, a selective 5-HT3 antagonist with anti-emetic properties, is described. The key intermediate involved is 6-bromo-1,2-dihydronaphthoid acid (5), which was synthesized from 4-bromophenylacetic acid by Micheal addition, acid-induced ring cyclization, reduction and dehydration. Compound (5) was selected because it has two labelling sites to ensure high specific activity of the final product. Reduction of amide 6 with carrier-free tritium gas, followed by reduction of the amide functional group with BF3-OEt2 and intramolecular cyclization furnished the title compound having a specific activity of 70.4 Ci/mmol and >99% purity.
View MoreShanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
Shandong Ailitong New Material Co.,Ltd
Contact:+86-536-3226266
Address:zhongjia village, putong town , qingzhou city,Shandong Province,China
Contact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
shandong lukang animal & plant drug trading co.,ltd.
Contact:15853765968
Address:floor 9, lukang ,jingying building,#173,taibai building west road,jining city,shandong,china
Contact:+86-512-56795332
Address:No227 Shuanglong Rd, Fenghuang, Zhangjiagang
Doi:10.1021/acs.jmedchem.9b01649
(2019)Doi:10.1016/j.bmcl.2010.08.043
(2010)Doi:10.1002/hlca.19960790321
(1996)Doi:10.1016/j.jorganchem.2007.11.023
(2008)Doi:10.1021/acsmedchemlett.5b00102
(2015)Doi:10.1016/0040-4020(96)00258-X
(1996)